Matthew D. Silverman

Special Counsel

Matt Silverman focuses on mergers and acquisitions, general corporate matters and securities law. Matt regularly advises publicly traded companies with respect to corporate governance, takeover preparedness and SEC reporting.

Download full bio 


  • Amazon to Acquire One Medical for $3.9 Billion 

  • Digital Shadows Agrees to Sell to ReliaQuest 

  • Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion 

  • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 

  • NeoPhotonics Agrees to Sell to Lumentum for $918 Million 

  • View all

Practices & Industries


    Film, Music, Surfing and Travel


  • Fordham University School of Law
    JD, cum laude, 2012

  • University of Vermont
    BA, Economics and Political Science
    Honors Program, 2006

Admissions & Credentials


New York